logo
logo

Wren Therapeutics Announces Financing of £12.4 Million (c. $17.0 Million)

Wren Therapeutics Announces Financing of £12.4 Million (c. $17.0 Million)

01/25/21, 8:04 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgcambridge
Money raised
£12 million
Wren Therapeutics Ltd., (“Wren”), a biopharmaceutical company pioneering a unique network kinetics approach to drug discovery for protein misfolding diseases, today announced the closing of a £12.4 million (c. $17.0 million) financing.

Company Info

Company
New Board Directors
Location
cambridge, maryland, united states
Additional Info
Andrew C. von Eschenbach, M.D., currently serves as president of Samaritan Health Initiatives Inc. and as a senior fellow at the Milken Institute and the Bipartisan Policy Center.